We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Breath Test Could Diagnose Colorectal Cancer

By LabMedica International staff writers
Posted on 19 Dec 2012
Print article
A simple breath analysis could be used for colorectal cancer screening, which should improve outcomes in gastrointestinal cancer patients.

Analysis of the volatile organic compounds (VOCs), which can be detected in the breath of cancer patients, is a new frontier in cancer screening as malignant tissues have different metabolism compared to normal healthy cells.

A team of scientist at the University Aldo Moro (Bari, Italy) collected exhaled breath from 37 patients with colorectal cancer and 41 healthy controls, which was processed offline to evaluate the VOC profile. The VOCs of interest had been identified and selected, and VOC patterns were able to discriminate patients from controls.

Exhaled breath was collected in a Tedlar, inert bag (Sigma-Aldrich, St Gallen, Switzerland) from patients with colorectal cancer and healthy controls who were negative at colonoscopy, and processed by thermal‐desorber gas chromatography–mass spectrometry to evaluate the VOC profile. A probabilistic neural network (PNN) validated by the leave‐one‐out method was used to identify the pattern of VOCs that better discriminated between the two groups.

Some 37 patients and 41 controls were included in the trial phase. Application of a PNN to a pattern of 15 compounds showed a discriminant performance with a sensitivity of 86%, a specificity of 83%, and an accuracy of 85% calculated as the area under the receiver operating characteristic (ROC) curve .The accuracy of PNN analysis was confirmed in the validation phase on a further 25 subjects and the model correctly assigned 19 patients, giving an overall accuracy of 76%.

Levels of some specific VOCs such as 1,3-dimethylbenzene, 1,2-pentadiene, cyclohexane, methylcyclohexane and 4-methyloctane were higher in patients with colorectal cancer than in controls. The authors concluded that the pattern of VOCs in patients with colorectal cancer was different from that in healthy controls. The PNN in this study was able to discriminate patients with colorectal cancer with an accuracy of over 75 %. Exhaled breath VOC analysis appears to have potential clinical application in colorectal cancer screening, although further studies are required to confirm its reliability in heterogeneous clinical settings.

Donato F. Altomare, MD, the senior author said, “The technique of breath sampling is very easy and noninvasive, although the method is still in the early phase of development. Our study's findings provide further support for the value of breath testing as a screening tool." The study was published on December 5, 2012, in the journal British Journal of Surgery (BJS).

Related Links:

University Aldo Moro
Sigma-Aldrich


Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Troponin I Test
Quidel Triage Troponin I Test
New
Piezoelectric Micropump
Disc Pump

Print article

Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.